Epsilon M&A Deal Report - Double Helix Bio-Technology Development
Transaction Multiples for the Valuation of Private Companies
Interpublic Group of Cos / Double Helix Bio-Technology Development
No EMAT :
58643
Announced Date :
25/06/2012
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Interpublic Group of Cos
Target :
Double Helix Bio-Technology Development
Country :
England
Sector of activity :
- Marketing & Communication Services > Media - Communication > Marketing Services
Business Description :
Founded in 1995 by Wayne Phillips, Double Helix is a pharmaceutical market access consultancy dedicated to the Life Sciences sector, providing pharmaceutical, biotech and medical device clients of...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
|
|
|
|
| Current |
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Marketing Services » = 197
| Date | Acquirer | Target | Country | Multiples | See details |
| 29/02/2012 | St Ives | Incite Marketing Planning | England | *** | 58629 |
| 07/02/2013 | Wilmington Group | NHiS | England | ** | 58622 |
Source: Epsilon Research / EMAT
